The Art of
Licensing 		The Art of
Development 		The Art of
Access 		The Art of
Manufacturing 		The Art of
Partnership
Home > The Art of Access > Our products > Cancer Supportive Care > Anamorelin
Anamorelin

Anamorelin

 amorelin2.gif

  • Anamorelin is a synthetic orally active ghrelin agonist with orexygenic properties which is under development for the management of cancer cachexia.
  • Development status: Phase 2-3.
 
Home
Legal Statement
News
Contacts
Sitemap
Document Central
Jobs
Helsinn′s Board of Directors and Top Management
Printer Friendly
Copyright © Helsinn Group - Legal Statement
Last Update: 01.09.2010
About Helsinn Our Products Our Partners